Search Within

CTCR Scholars

Formats
  1. Meeting Abstract (873)
  2. Journal Article (564)
  3. Review (72)
  4. Research Letter (38)
  5. Editorial (29)
  6. Correspondence (24)
  7. Miscellaneous (17)
  8. Book Section (11)
  9. Guidelines (7)
  10. Conference Paper (4)
Groups
  1. Department of Medicine (1415)
  2. Hematologic Malignancies, Division of (1082)
  3. MSK Grad Students (1018)
  4. Center for Hematologic Malignancies (985)
  5. Master of Science in Clinical and Translational Cancer Research (983)
  6. Survivorship Research (917)

More Groups

People
  1. Sergio Giralt (553)
  2. Miguel-Angel Perales (411)
  3. Michael Scordo (385)
  4. Gunjan Shah (341)
  5. Sean Devlin (333)
  6. Parastoo Dahi (305)

More People

Years
  1. 2025 (98)
  2. 2024 (251)
  3. 2023 (261)
  4. 2022 (230)
  5. 2021 (166)
  6. 2020 (211)

More Years

Publications
  1. Blood (318)
  2. Biology of Blood and Marrow Transplantation (187)
  3. Journal of Clinical Oncology (144)
  4. Annals of Surgical Oncology (83)
  5. Bone Marrow Transplantation (65)
  6. Transplantation and Cellular Therapy (56)

More Publications

Publishers
  1. Elsevier Inc. (390)
  2. American Society of Hematology (372)
  3. American Society of Clinical Oncology (158)
  4. Nature Publishing Group (134)
  5. Springer (102)
  6. American Association for Cancer Research (65)

More Publishers

Results (1639)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Substance-related found-down compartment syndrome: A systematic review
    Review

    Mortensen, S. J.; Smith, R. D. J.; von Keudell, G. R.; Smith, M. R.; Weaver, M. J.; Nazarian, A.; von Keudell, A. G.
    Journal of Orthopaedic Trauma (2021)

    Fulltext@MSK | Save
  • Acute GVHD diagnosis and adjudication in a multicenter trial: A report From the BMT CTN 1202 biorepository study
    Journal Article

    Reshef, R.; Saber, W.; Bolaños-Meade, J.; Chen, G.; Chen, Y. B.; Ho, V. T.; Ponce, D. M.; Nakamura, R.; Martens, M. J.; Hansen, J. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Tailoring therapy to be just right in HER2-positive early-stage breast cancer: The Goldilocks problem
    Editorial

    Drago, J. Z.; Jhaveri, K.
    JCO Oncology Practice (2021)

    Fulltext@MSK | Save
  • Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse
    Journal Article

    Bobillo, S.; Joffe, E.; Sermer, D.; Mondello, P.; Ghione, P.; Caron, P. C.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Kumar, A.; more...
    Blood Cancer Journal (2021)

    Fulltext@MSK | Save
  • Histologic subtype defines the risk and kinetics of recurrence and death for primary extremity/truncal liposarcoma
    Journal Article

    Bartlett, E. K.; Curtin, C. E.; Seier, K.; Qin, L. X.; Hameed, M.; Yoon, S. S.; Crago, A. M.; Brennan, M. F.; Singer, S.
    Annals of Surgery (2021)

    Fulltext@MSK | Save
  • Genome-wide chromatin analysis of FFPE tissues using a dual-arm robot with clinical potential
    Journal Article

    Kaneko, S.; Mitsuyama, T.; Shiraishi, K.; Ikawa, N.; Shozu, K.; Dozen, A.; Machino, H.; Asada, K.; Komatsu, M.; Kukita, A.; more...
    Cancers (2021)

    Fulltext@MSK | Save
  • Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors
    Journal Article

    Dunbar, A.; Bolton, K. L.; Devlin, S. M.; Sanchez-Vega, F.; Gao, J.; Mones, J. V.; Wills, J.; Kelly, D.; Farina, M.; Cordner, K. B.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Cellular therapy during COVID-19: Lessons learned and preparing for subsequent waves
    Journal Article

    Nawas, M. T.; Shah, G. L.; Feldman, D. R.; Ruiz, J. D.; Robilotti, E. V.; Aslam, A. A.; Dundas, M.; Kamboj, M.; Barker, J. N.; Cho, C.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Getting blood out of a stone: Identification and management of patients with poor hematopoietic cell mobilization
    Review

    Chen, J.; Lazarus, H. M.; Dahi, P. B.; Avecilla, S.; Giralt, S. A.
    Blood Reviews (2021)

    Fulltext@MSK | Save
  • Tailored treatment to MRD response: A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice-weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone
    Research Letter

    Korde, N.; Mastey, D.; Tavitian, E.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Smith, E. L.; Lendvai, N.; Hultcrantz, M.; Shah, U.; more...
    American Journal of Hematology (2021)

    Fulltext@MSK | Save